Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Show more...
FAQ
Imunon 今天的股价是多少?▼
CBO0.F 当前价格为 €2.16 EUR,在过去 24 小时内下跌了 -1.82%。在图表上更密切关注 Imunon 股票的表现。
Imunon 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Imunon 的股票以代码 CBO0.F 进行交易。
Imunon 的股价在上涨吗?▼
CBO0.F 股票较上周下跌 -1.82%,本月下跌 -12.2%,过去一年 Imunon 下跌 -85.15%。
Imunon 的市值是多少?▼
今天 Imunon 的市值为 6.63M
Imunon 下一次财报日期是什么时候?▼
Imunon 将于 五月 18, 2026 发布下一次财报。
Imunon 去年的营收是多少?▼
Imunon 去年的营收为 0EUR。
Imunon 去年的净利润是多少?▼
CBO0.F 去年的净收益为 -35.29MEUR。
Imunon 有多少名员工?▼
截至四月 02, 2026,公司共有27名员工。
Imunon 属于哪个行业?▼
Imunon从事于Manufacturing行业。
Imunon 何时完成拆股?▼
Imunon 上次拆股发生在 八月 07, 2025,比例为 1.15:1。
Imunon 的总部在哪里?▼
Imunon 的总部位于 US 的 Lawrence Township。